Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Clinical trial NCT06609239 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06609239
- Sponsor
- Sanofi
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-30
- Primary completion
- 2031-01-20
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.